Firmagon and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Firmagon (degarelix acetate) and Gabapentin (gabapentin). Common drug interactions include fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Firmagon and Gabapentin. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Firmagon?

Firmagon has active ingredients of degarelix acetate. It is often used in prostate cancer. eHealthMe is studying from 3,274 Firmagon users. Check the latest studies of Firmagon.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

51 people who take Firmagon and Gabapentin together, and have interactions are studied.

Firmagon and Gabapentin drug interactions.

What are the common drug interactions of Firmagon and Gabapentin, by gender? *:

female:

n/a

male:

Fatigue (feeling of tiredness)
Prostatic specific antigen increased
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Malaise (a feeling of general discomfort or uneasiness)
Sinusitis (inflammation of sinus)
Abdominal pain upper
Arthralgia (joint pain)
Balance disorder
Cough

What are the common drug interactions of Firmagon and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Nocturia (the need to get up in the night to urinate)
Abasia (inability to walk)
Back pain
Death
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Injection site pain
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Pain in extremity
Urinary bladder haemorrhage (urinary bladder bleeding)

60+:

Fatigue (feeling of tiredness)
Prostatic specific antigen increased
Sinusitis (inflammation of sinus)
Arthralgia (joint pain)
Death
Decreased appetite
Hypotension (abnormally low blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Muscular weakness (muscle weakness)
Abdominal pain upper

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 6 people, 11.76%
High Blood Pressure: 5 people, 9.80%
Cardiac Disorder: 4 people, 7.84%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 5.88%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 5.88%
Pain: 3 people, 5.88%
Neuralgia (pain in one or more nerves): 3 people, 5.88%
Metastases To Bone (cancer spreads to bone): 3 people, 5.88%
High Blood Cholesterol: 3 people, 5.88%
Diabetes: 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Firmagon and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously